Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/8/2025

Meropenem Safety in Patients with Penicillin Allergy

Cross-reactivity Between Penicillins and Carbapenems

  • The risk of cross-reactivity between penicillins and any carbapenem is only 0.87% (95% CI: 0.32%-2.32%) 2
  • Multiple guidelines strongly recommend that patients with suspected immediate-type penicillin allergy can receive any carbapenem without prior allergy testing 1, 3, 4
  • The Dutch Working Party on Antibiotic Policy (SWAB) guidelines recommend that patients with suspected immediate-type penicillin allergy can receive any carbapenem without prior allergy testing 1, 3

Clinical Evidence Supporting Safety

  • No unique non-redundant facts are available in this section that do not contain [ignore ref]

Important Considerations and Precautions

  • No unique non-redundant facts are available in this section that do not contain [ignore ref]

Practical Approach

  • The American College of Clinical Microbiology recommends proceeding with meropenem administration without prior testing in patients with a history of penicillin allergy 1, 2
  • Monitor for potential hypersensitivity reactions during the first dose, especially in patients with a history of severe reactions 2
  • For patients with non-severe delayed-type penicillin allergy, carbapenems can be administered without special precautions 1, 5